4//SEC Filing
HIPP RAYMOND R 4
Accession 0001077183-19-000156
CIK 0001077183other
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 5:44 PM ET
Size
17.7 KB
Accession
0001077183-19-000156
Insider Transaction Report
Form 4
HIPP RAYMOND R
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2019-08-23−2,777→ 0 totalExercise: $9.11From: 2017-07-28Exp: 2021-07-28→ Common Stock (2,777 underlying) - Exercise/Conversion
Common Stock
2019-08-23$11.60/sh+3,017$34,997→ 144,016 total - Exercise/Conversion
Common Stock
2019-08-23$7.27/sh+3,333$24,231→ 147,349 total - Exercise/Conversion
Common Stock
2019-08-23$9.11/sh+2,777$25,298→ 150,126 total - Sale
Common Stock
2019-08-26$24.79/sh−15,424$382,361→ 134,102 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-08-23−3,333→ 3,334 totalExercise: $7.27From: 2018-05-25Exp: 2022-05-25→ Common Stock (6,667 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2019-08-23−3,017→ 0 totalExercise: $11.60From: 2019-06-01Exp: 2023-06-01→ Common Stock (3,017 underlying) - Sale
Common Stock
2019-08-23$25.02/sh−600$15,012→ 149,526 total
Holdings
- 4,269
Stock Option (Right to Buy)
Exercise: $22.52From: 2020-06-06Exp: 2026-06-06→ Common Stock (4,269 underlying)
Footnotes (2)
- [F1]On July 28, 2016, Mr. Hipp was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- [F2]On May 25, 2017, Mr. Hipp was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001188214
Filing Metadata
- Form type
- 4
- Filed
- Aug 26, 8:00 PM ET
- Accepted
- Aug 27, 5:44 PM ET
- Size
- 17.7 KB